NEWPHARMA.DK ApS: Financial statements 2013
CVR: 31431824
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
NEWPHARMA.DK ApS (CVR 31431824) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 1,133,770 and a net result of DKK 1,020,452. That is an increase of 188.4% compared with the year before. Equity in the 2013 report amounted to DKK 1,639,292. The solvency ratio was 77.5%.
- Gross Profit
- DKK 1,133,770
- Profit/Loss
- DKK 1,020,452
- Equity
- DKK 1,639,292
- Total Assets
- DKK 2,114,781
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 1.1 mio. | 1 mio. | 1.6 mio. | - |
| 2012 | - | 393 t. | - | - | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
NEWPHARMA.DK ApS has published its annual report for 2012.
About NEWPHARMA.DK ApS
NEWPHARMA.DK ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company has been dissolved on 16 November 2015. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2013, the company reported a gross profit of DKK 1,133,770 and a net result of DKK 1,020,452. Equity in the 2013 report amounted to DKK 1,639,292.